Literature DB >> 2882542

Delusional depression: phenomenology and response to treatment.

E Lykouras, D Malliaras, G N Christodoulou, G Moussas, D Christodoulou, A Tzonou.   

Abstract

In this retrospective study demographic and clinical characteristics, personality traits, family psychiatric history and response to treatment were compared in 55 delusional and 40 nondelusional hospitalized patients who met DSM-III criteria for major depression. Male delusional depressives had a greater frequency of delusional ideas at the index episode than female delusionals. Delusional depressives had a greater frequency of family history for alcoholism, a smaller frequency of previous depressive episodes and tended to respond more favorably to treatment with electroconvulsive therapy or tricyclic antidepressants combined with neuroleptics than to antidepressants alone. The findings and the implications arising from them are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2882542     DOI: 10.1159/000284441

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  3 in total

1.  An open trial of a new acceptance-based behavioral treatment for major depression with psychotic features.

Authors:  Brandon A Gaudiano; Kathryn Nowlan; Lily A Brown; Gary Epstein-Lubow; Ivan W Miller
Journal:  Behav Modif       Date:  2012-12-06

2.  A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.

Authors:  Kristina M Deligiannidis; Anthony J Rothschild; Bruce A Barton; Aimee R Kroll-Desrosiers; Barnett S Meyers; Alastair J Flint; Ellen M Whyte; Benoit H Mulsant
Journal:  J Clin Psychiatry       Date:  2013-10       Impact factor: 4.384

3.  Structural brain networks in remitted psychotic depression.

Authors:  Nicholas H Neufeld; Antonia N Kaczkurkin; Aristeidis Sotiras; Benoit H Mulsant; Erin W Dickie; Alastair J Flint; Barnett S Meyers; George S Alexopoulos; Anthony J Rothschild; Ellen M Whyte; Linda Mah; Jay Nierenberg; Matthew J Hoptman; Christos Davatzikos; Theodore D Satterthwaite; Aristotle N Voineskos
Journal:  Neuropsychopharmacology       Date:  2020-02-28       Impact factor: 8.294

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.